Welcome to our dedicated page for OneMedNet SEC filings (Ticker: ONMDW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings associated with OneMedNet Corp (ONMDW) and OneMedNet Corporation, a Nasdaq-listed healthcare software and data company focused on digital medical imaging and regulatory-grade imaging Real World Data (RWD). These documents offer detailed insight into the company’s capital structure, warrant terms, financing transactions, and other material events.
Recent Form 8-K filings describe redeemable warrants, each exercisable for one share of common stock at a specified exercise price, as well as the company’s common stock with a stated par value. Filings also outline private placements of common stock and pre-funded warrants, voting agreements with investors, subscription agreements with certain shareholders, and conversions of shareholder and other loans into common stock. Additional disclosures discuss the settlement of trade payables and other current liabilities, and the posting of investor presentations furnished as exhibits.
Through these SEC reports, readers can review how OneMedNet raises capital, structures its equity and warrant offerings, and manages its liabilities and working capital. Items such as unregistered sales of equity securities, entries into material definitive agreements, and other events are described in the relevant sections of the filings.
On Stock Titan, SEC documents are updated in near real time from the EDGAR system. AI-powered summaries help explain the key points of lengthy filings, including 8-K current reports and, where available, registration statements and periodic reports such as 10-K annual reports and 10-Q quarterly reports. Users can quickly see the main terms of warrant issuances, equity financings, and liability settlements without reading every page.
For investors analyzing ONMDW and related securities, this page serves as a focused entry point to OneMedNet’s regulatory disclosures, with tools that highlight important sections, clarify technical language, and make it easier to interpret the implications of each filing.
OneMedNet Corporation filed its annual report describing a niche business curating regulatory-grade imaging Real World Data for life sciences customers through a federated network of more than 2,130 healthcare sites. The company remains unprofitable, with net losses of $2.8 million in 2025 and $10.1 million in 2024 and an accumulated deficit of about $104.4 million, and its auditors raised substantial doubt about its ability to continue as a going concern. Management highlights a highly regulated, competitive environment, a workforce of roughly 23 employees, and heavy reliance on data privacy, cybersecurity and FDA-quality compliance. During 2025, OneMedNet completed equity financings, insider-led subscriptions and multiple debt-for-equity conversions that together eliminated roughly $11.9 million of current liabilities, which it states equals a 62% reduction in total liabilities outstanding as of year-end 2025, while also detailing extensive regulatory, operational and market risks.
OneMedNet reported mixed results: operating revenue declined while non-operating items improved the bottom line. Total revenue was $155 thousand for the quarter (subscription $47k; web imaging $108k), down from $227k year-over-year, and gross margin was negative $(241)k. The company recorded net income of $2.98 million for the quarter and $1.08 million for the six months, driven largely by a $3.71 million gain on troubled debt restructurings, realized Bitcoin gains, and fair value adjustments.
Balance sheet and liquidity remain constrained: cash was $122k and Bitcoin fair value $1.598 million (15 units), total assets $2.337 million, and total liabilities fell to $6.177 million from $19.677 million due to debt-to-equity conversions and settlements. Stockholders' deficit improved to $(3.84) million. Management states the cash and Bitcoin balance are not adequate to fund operations for 12 months, raising substantial doubt about going concern and requiring additional financing.